We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00283348
First Posted: January 27, 2006
Last Update Posted: March 20, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Virginia Commonwealth University
  Purpose
The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation and affects the function of the transplanted kidney. It is hoped that by studying blood, urine, and tissue samples of kidney transplant patients, new ways of diagnosing and treating CAN may be found.

Condition
Chronic Rejection

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy

Resource links provided by NLM:


Further study details as provided by Virginia Commonwealth University:

Biospecimen Retention:   Samples With DNA
Blood, Urine

Enrollment: 121
Study Start Date: January 2006
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients Diagnosis of Chronic Allograft Nephropathy at VCUHS Clinic
Criteria

Inclusion Criteria:

  • Received primary kidney transplant Diagnosis of Chronic Allograft Nephropathy Stable immunosuppression for one month prior to entry

Exclusion Criteria:

  • Serious comorbidity Pregnancy Retransplantation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00283348


Locations
United States, Virginia
VCU Health System
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
Virginia Commonwealth University
Hoffmann-La Roche
Investigators
Principal Investigator: Daniel G Maluf, MD Virginia Commonwealth University
Principal Investigator: Valeria Mas, Ph.D. Virginia Commonwealth University
  More Information

Responsible Party: Virginia Commonwealth University
ClinicalTrials.gov Identifier: NCT00283348     History of Changes
Other Study ID Numbers: Cell 500
First Submitted: January 25, 2006
First Posted: January 27, 2006
Last Update Posted: March 20, 2017
Last Verified: March 2017

Keywords provided by Virginia Commonwealth University:
Renal Transplantation
Immunosuppression
Chronic Rejection